Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D'Arpa

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Determinants of cellular sensitivity to topoisomerase-targeting antitumor drugsP D'Arpa
The Journal of Investigative Dermatology|July 1, 1981
Epigenetic and genetic factors in the cellular response to radiations and DNA-damaging chemicalsJ R Williams, P D'Arpa
Oncology Research|November 5, 1998
Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell linesA E Borovitskaya, P D'Arpa
Experimental Cell Research|March 1, 1995
Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase IP D'Arpa, L F Liu
Important Advances in Oncology|January 1, 1992
Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistanceL F Liu, P D'Arpa
Biochimica Et Biophysica Acta|December 17, 1989
Topoisomerase-targeting antitumor drugsP D'Arpa, L F Liu
Cancer Research|November 1, 1990
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisonsP D'Arpa, C Beardmore, L F Liu
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|January 1, 1990
A model for tumor cell killing by topoisomerase poisonsH Zhang, P D'Arpa, L F Liu
Cancer Research|April 1, 1992
The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin BY P Tsao, P D'Arpa, L F Liu
Mutation Research|September 18, 1998
The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replicationL R Barrows, J A Holden, M Anderson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Determinants of cellular sensitivity to topoisomerase-targeting antitumor drugsP D'Arpa
The Journal of Investigative Dermatology|July 1, 1981
Epigenetic and genetic factors in the cellular response to radiations and DNA-damaging chemicalsJ R Williams, P D'Arpa
Oncology Research|November 5, 1998
Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell linesA E Borovitskaya, P D'Arpa
Experimental Cell Research|March 1, 1995
Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase IP D'Arpa, L F Liu
Important Advances in Oncology|January 1, 1992
Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistanceL F Liu, P D'Arpa
Biochimica Et Biophysica Acta|December 17, 1989
Topoisomerase-targeting antitumor drugsP D'Arpa, L F Liu
Cancer Research|November 1, 1990
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisonsP D'Arpa, C Beardmore, L F Liu
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|January 1, 1990
A model for tumor cell killing by topoisomerase poisonsH Zhang, P D'Arpa, L F Liu
Cancer Research|April 1, 1992
The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin BY P Tsao, P D'Arpa, L F Liu
Mutation Research|September 18, 1998
The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replicationL R Barrows, J A Holden, M Anderson, et al.
Pageof 2